Skip to Content

Join the 'Xiidra' group to help and get support from people like you.

Xiidra News

FDA Approves Xiidra (lifitegrast ophthalmic solution) for Dry Eye Disease

Posted 1 Aug 2016 by Drugs.com

July 12, 2016 – The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen 1 (LFA-1) antagonist, approved by the FDA for dry eye disease. “Normal tear production is needed for clear vision and eye health,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “This approval will provide a new treatment option for patients with dry eye disease.” Dry eye disease includes a group of conditions in which the eye does not produce an adequate volume of tears or when the tears are not of the correct consistency. The chance of experiencing dry eye increases with age, affecting approximately five percent of the ... Read more

Related support groups: Xiidra, Dry Eye Disease, Lifitegrast

Ask a Question

Further Information

Related Condition Support Groups

Dry Eye Disease

Xiidra Patient Information at Drugs.com